Analysts’ Viewpoint
The U.S. itchy scalp treatment market is expected to be driven by rise in prevalence of scalp-related disorders such as dandruff, psoriasis, and seborrheic dermatitis. Increase in awareness among consumers about the importance of scalp health and hygiene is likely to drive U.S. itchy scalp treatment industry growth. Furthermore, adoption of advanced technologies such as artificial intelligence and machine learning in the development of scalp treatments is expected to drive market expansion in the next few years.
Development of innovative products and increase in demand for organic and natural products offer lucrative opportunities to market players. Companies are focusing on introducing more effective and low cost products in order to increase market share and presence.
However, availability of alternative treatment options, such as home remedies and natural products, is likely to act as a restraint of the market.
Scalp-related problems include dandruff, psoriasis, and seborrheic dermatitis. These conditions cause itching, flaking, and irritation of the scalp. A range of products designed to provide relief from these conditions are available in the market in the U.S. These include shampoos, conditioners, hair masks, and scalp treatments.
Shampoos are the most commonly used products in the U.S. itchy scalp treatment market. These are designed to cleanse the scalp and hair while providing relief from itching and irritation. Some of the popular ingredients used in these shampoos include tea tree oil, salicylic acid, and ketoconazole.
Conditioners are used to provide moisture to the hair and scalp, which helps in reducing itching and flaking. Hair masks are used in dry scalp treatment to provide deep conditioning to the hair and scalp, which helps in reducing dryness and irritation. Scalp treatments are used to provide targeted relief to the scalp, which helps in reducing itching and flaking.
Overall, the U.S. itchy scalp treatment market offers a range of products that cater to the needs of individuals suffering from scalp-related issues.
Scalp conditions such as dandruff, psoriasis, and seborrheic dermatitis are becoming increasingly common in the U.S. According to a study published in the Journal of Investigative Dermatology, around 50 million people in the country suffer from dandruff. Prevalence of these scalp conditions is expected to increase due to pollution, stress, and unhealthy lifestyles.
Rise in scalp conditions has led to an increase in U.S. itchy scalp treatment market demand. Consumers are looking for effective solutions that can provide relief from itching and flaking caused by these conditions. This offers significant business opportunities to market players to develop innovative products that cater to specific needs of consumers.
Increase in awareness about personal grooming and hygiene among consumers is propelling demand for hair care products that not only cleanse, but also treat various scalp conditions. This is expected to drive U.S. itchy scalp treatment market value during the forecast period.
Consumers are becoming more conscious about what they put on their skin and hair. They are opting for natural ingredients over synthetic ones due to concerns regarding potential side effects associated with chemical-based products. This trend is particularly evident in the itchy scalp treatment market where consumers prefer natural remedies such as tea tree oil, coconut oil, apple cider vinegar, etc., which have been traditionally used for treating various scalp conditions.
Companies operating in the market have recognized this trend and are launching new products containing natural ingredients or reformulating existing ones with natural extracts or oils. For instance, Head & Shoulders launched a line of shampoos containing tea tree oil while Neutrogena introduced a range of anti-dandruff shampoos infused with naturally derived salicylic acid extracted from willow bark.
In terms of product type, the shampoo segment accounted for the largest U.S. itchy scalp treatment market share in 2022.
Consumers are increasingly becoming aware of the benefits of using shampoo for treating itchy scalp as compared to other products. Shampoos contain active ingredients such as salicylic acid and coal tar that help in reducing inflammation and itching on the scalp. Moreover, shampoos are easy to use and can be incorporated into daily hair care routine without any hassle.
Demand for natural and organic shampoos has increased among consumers due to their perceived health benefits. Natural shampoos used in dry itchy scalp treatment or itchy scalp remedy do not contain harsh chemicals such as sulfates that can strip off natural oils from hair leading to dryness and itchiness on scalp. Instead, these use plant-based ingredients such as tea tree oil or peppermint oil, which have anti-inflammatory properties that soothe irritated scalps.
Manufacturers are constantly innovating by introducing new variants with added benefits such as dandruff control or moisturizing properties, which cater to specific consumer needs. For instance, in June 2021, Procter & Gamble launched its Head & Shoulders Supreme Nourish & Smooth Collection, which claims to provide nourishment along with smoothness for frizzy hair types.
Based on dosage form, the liquid form segment dominated the U.S. itchy scalp treatment market in 2022. Liquid form products such as scalp tonics or serums are easy to apply directly on the affected area without any messiness or inconvenience. These also get absorbed quickly into the scalp providing faster relief from itching and irritation.
Demand for leave-in treatments that provide long-lasting benefits throughout the day is increasing. Liquid form products can be applied once in the morning and left on hair all day without any need for rinsing off, thereby providing continuous relief from itchy scalp.
Manufacturers are introducing new ingredients such as menthol or eucalyptus oil, which have cooling properties that provide instant relief from itchiness in contact with the skin. For instance, in May 2021, Johnson & Johnson launched its Neutrogena T/Gel Cooling Shampoo, which contains menthol that provides a cooling sensation while reducing dandruff and flakiness.
Consumers are increasingly becoming health conscious and prefer using products that do not contain harmful chemicals, such as parabens or sulfates, which can cause further damage to already irritated scalps. Liquid form products often use natural ingredients, including tea tree oil or chamomile extract, which have anti-inflammatory properties making them more appealing to consumers who prioritize natural remedies for itchy scalp over chemical ones.
The U.S. itchy scalp treatment market report includes vital information about the key companies operating in the U.S. itchy scalp treatment market. Companies focus on strategies such as product launches, divestiture, mergers & acquisitions (M&A), and partnerships to strengthen their position in the market.
Arcadia Consumer Healthcare (Bansk Group), Hill Dermaceuticals, Inc., Merck & Co., Inc., Mylan N.V. (Viatris, Inc.), Teva Pharmaceutical Industries Ltd., and The Procter & Gamble Company are the prominent players operating in the market.
Each of these players in the market has been profiled in the report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
Attribute |
Detail |
Size in 2022 |
US$ 782.3 Mn |
Forecast (Value) in 2031 |
More than US$ 1.2 Bn |
Compound Annual Growth Rate (CAGR) |
4.6% |
Forecast Period |
2023-2031 |
Historical Data Available for |
2017-2021 |
Quantitative Units |
US$ Mn/Bn for Value |
Market Analysis |
It includes segment analysis as well as country level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
Competition Landscape |
|
Format |
Electronic (PDF) + Excel |
Market Segmentation |
|
Companies Profiled |
|
Customization Scope |
Available upon request |
Pricing |
Available upon request |
It was valued at US$ 782.3 Mn in 2022
It is projected to reach more than US$ 1.2 Bn by 2031
The market in the country is anticipated to expand at a CAGR of 4.6% from 2023 to 2031
Rise in prevalence of scalp conditions and increase in preference for natural ingredients are driving the market in the country
The shampoo segment accounted for the leading share of the industry in 2022
Arcadia Consumer Healthcare (Bansk Group), Hill Dermaceuticals, Inc., Merck & Co., Inc., Mylan N.V. (Viatris, Inc.), Teva Pharmaceutical Industries Ltd. and The Procter & Gamble Company
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: U.S. Itchy Scalp Treatment Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. U.S. Itchy Scalp Treatment Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Porter’s Five Force Analysis
5.2. Disease Prevalence & Incidence Rate
5.3. Pricing Analysis
5.4. Overview and Applications of OTC Products in Treatment of Itchy Scalp
5.5. COVID-19 Impact Analysis
6. U.S. Itchy Scalp Treatment Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value & Volume Forecast, by Product Type, 2017–2031
6.3.1. Shampoo
6.3.1.1. Salicylic Acid
6.3.1.2. Coal Tar
6.3.1.3. Zinc Pyrithione
6.3.1.4. Ketoconazole
6.3.1.5. Others
6.3.2. Topical Steroids
6.3.2.1. Fluocinolone
6.3.2.2. Clobetasol
6.3.2.3. Desonide
6.3.2.4. Others
6.3.3. Moisturizer
6.3.4. Conditioner
6.3.5. Scalp Revitalizer & Toner
6.3.6. Others
6.4. Market Attractiveness Analysis, by Product Type
7. U.S. Itchy Scalp Treatment Market Analysis and Forecast, by Distribution Channel
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Distribution Channel, 2017–2031
7.3.1. Hospital Channels
7.3.2. Retail Pharmacies/Stores
7.3.3. Online Stores/Pharmacies
7.3.4. Others
7.4. Market Attractiveness Analysis, by Distribution Channel
8. U.S. Itchy Scalp Treatment Market Analysis and Forecast, by Sales Type
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value & Volume Forecast, by Sales Type, 2017–2031
8.3.1. Rx Sales
8.3.2. OTC Sales
8.4. Market Attractiveness Analysis, by Sales Type
9. U.S. Itchy Scalp Treatment Market Analysis and Forecast, by Dosage Form
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by Dosage Form, 2017–2031
9.3.1. Oral Form
9.3.2. Oil Form
9.3.3. Liquid Form
9.3.4. Others
9.4. Market Attractiveness Analysis, by Dosage Form
10. Competition Landscape
10.1. Market Player - Competition Matrix (by tier and size of companies)
10.2. Market Share Analysis, by Company, 2021
10.3. Company Profiles
10.3.1. Arcadia Consumer Healthcare (Bansk Group)
10.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.1.2. Test Type Portfolio
10.3.1.3. Financial Overview
10.3.1.4. SWOT Analysis
10.3.1.5. Strategic Overview
10.3.2. Hill Dermaceuticals, Inc.
10.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.2.2. Test Type Portfolio
10.3.2.3. Financial Overview
10.3.2.4. SWOT Analysis
10.3.2.5. Strategic Overview
10.3.3. Merck & Co., Inc.
10.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.3.2. Test Type Portfolio
10.3.3.3. Financial Overview
10.3.3.4. SWOT Analysis
10.3.3.5. Strategic Overview
10.3.4. Mylan N.V. (Viatris, Inc.)
10.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.4.2. Test Type Portfolio
10.3.4.3. Financial Overview
10.3.4.4. SWOT Analysis
10.3.4.5. Strategic Overview
10.3.5. Teva Pharmaceutical Industries Ltd.
10.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.5.2. Test Type Portfolio
10.3.5.3. Financial Overview
10.3.5.4. SWOT Analysis
10.3.5.5. Strategic Overview
10.3.6. The Procter & Gamble Company
10.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
10.3.6.2. Test Type Portfolio
10.3.6.3. Financial Overview
10.3.6.4. SWOT Analysis
10.3.6.5. Strategic Overview
List of Tables
Table 01: U.S. Itchy Scalp Treatment Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
Table 02: U.S. Itchy Scalp Treatment Market Value (US$ Mn) Forecast, by Shampoo, 2017-2031
Table 03: U.S. Itchy Scalp Treatment Market Value (US$ Mn) Forecast, by Topical Steroids, 2017-2031
Table 04: U.S. Itchy Scalp Treatment Market Volume (Million Units) Forecast, by Product Type, 2017-2031
Table 05: U.S. Itchy Scalp Treatment Market Volume (Million Units) Forecast, by Shampoo, 2017-2031
Table 06: U.S. Itchy Scalp Treatment Market Volume (Million Units) Forecast, by Topical Steroids, 2017-2031
Table 07: U.S. Itchy Scalp Treatment Market Value (US$ Mn) Forecast, by Dosage Form, 2017‒2031
Table 08: U.S. Itchy Scalp Treatment Market Value (US$ Mn) Forecast, by Sales Type, 2017‒2031
Table 09: U.S. Itchy Scalp Treatment Market Volume (Million Units) Forecast, by Sales Type, 2017‒2031
Table 10: U.S. Itchy Scalp Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2017‒2031
List of Figures
Figure 01: U.S. Itchy Scalp Treatment Market Share, by Product Type, 2022
Figure 02: U.S. Itchy Scalp Treatment Market Share, by Dosage Form, 2022
Figure 03: U.S. Itchy Scalp Treatment Market Share, by Sales Type, 2022
Figure 04: U.S. Itchy Scalp Treatment Market Share, by Distribution Channel, 2022
Figure 05: U.S. Itchy Scalp Treatment Market Value (US$ Bn) Forecast, 2017-2031
Figure 06: U.S. Itchy Scalp Treatment Market Value (US$ Mn), by Product, 2022
Figure 07: U.S. Itchy Scalp Treatment Market Value (US$ Mn), by Dosage Form, 2022
Figure 08: U.S. Itchy Scalp Treatment Market Value (US$ Mn), by Sales Type, 2022
Figure 09: U.S. Itchy Scalp Treatment Market Value (US$ Mn), by Distribution Channel, 2022
Figure 10: U.S. Itchy Scalp Treatment Market Value Share Analysis, by Product Type 2022 and 2031
Figure 11: U.S. Itchy Scalp Treatment Market Attractiveness Analysis, Product Type, 2023-2031
Figure 12: U.S. Itchy Scalp Treatment Market Revenue (US$ Mn), by Shampoo, 2017-2031
Figure 13: U.S. Itchy Scalp Treatment Market Revenue (US$ Mn), by Topical Steroids, 2017-2031
Figure 14: U.S. Itchy Scalp Treatment Market Revenue (US$ Mn), by Moisturizer, 2017-2031
Figure 15: U.S. Itchy Scalp Treatment Market Revenue (US$ Mn), by Conditioner, 2017-2031
Figure 16: U.S. Itchy Scalp Treatment Market Revenue (US$ Mn), by Scalp Revitalizer & Toner, 2017-2031
Figure 17: U.S. Itchy Scalp Treatment Market Revenue (US$ Mn), by Others, 2017-2031
Figure 18: U.S. Itchy Scalp Treatment Market Value Share Analysis, by Dosage Form, 2022 and 2031
Figure 19: U.S. Itchy Scalp Treatment Market Attractiveness Analysis, by Dosage Form 2023-2031
Figure 20: U.S. Itchy Scalp Treatment Market Value (US$ Mn), by Oral Form, 2017-2031
Figure 21: U.S. Itchy Scalp Treatment Market Value (US$ Mn), by Oil Form, 2017-2031
Figure 22: U.S. Itchy Scalp Treatment Market Value (US$ Mn), by Liquid Form, 2017-2031
Figure 23: U.S. Itchy Scalp Treatment Market Value (US$ Mn), by Others, 2017-2031
Figure 24: U.S. Itchy Scalp Treatment Market Value Share Analysis, by Sales Type, 2022 and 2031
Figure 25: U.S. Itchy Scalp Treatment Market Attractiveness Analysis, by Sales Type 2023-2031
Figure 26: U.S. Itchy Scalp Treatment Market Value (US$ Mn), by Rx Sales, 2017-2031
Figure 27: U.S. Itchy Scalp Treatment Market Value (US$ Mn), by OTC Sales, 2017-2031
Figure 28: U.S. Itchy Scalp Treatment Market Value Share Analysis, by Distribution Channel, 2022 and 2031
Figure 29: U.S. Itchy Scalp Treatment Market Attractiveness Analysis, by Distribution Channel 2023-2031
Figure 30: U.S. Itchy Scalp Treatment Market Value (US$ Mn), by Hospital Channels, 2017-2031
Figure 31: U.S. Itchy Scalp Treatment Market Value (US$ Mn), by Retail Pharmacies/Stores, 2017-2031
Figure 32: U.S. Itchy Scalp Treatment Market Value (US$ Mn), by Online Stores/Pharmacies, 2017-2031
Figure 33: U.S. Itchy Scalp Treatment Market Value (US$ Mn), by Others, 2017-2031
Figure 34: Market Share Analysis, by Company, 2022